NIH's top vaccine director retires, adding to the exodus of government vaccine expertise
After more than 20 years of working at NIH, John Mascola, director of NIAID’s vaccine research center and lead on vaccines for Operation Warp Speed, said Wednesday that he will retire at the end of March.
Mascola, who follows the recent departure of NIH director Francis Collins, was at the center of efforts to develop not only Moderna’s legendary Covid-19 vaccine, which has now been administered in millions of people, but also monoclonal antibodies used to treat Covid-19.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 153,800+ biopharma pros reading Endpoints daily — and it's free.